Pfizer

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues. In 2020, 52% of the company's revenues came from the United States, 6% came from each of China and Japan, and 36% came from other countries. Pfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to August 2020. The company ranks 64th on the Fortune 500 and 49th on the Forbes Global 2000.

Read more in the app

Pfizer is betting big on cancer drugs to turn business around after Covid decline

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

New Migraine Drug Offers Sufferers Hope Of ‘Fast-Acting Relief’ Via Nasal Spray, Pfizer Says

No, Project Veritas Video Doesn’t Prove Pfizer Is Mutating Covid-19, Who Is Jordon Trishton Walker?

InnovationRx: Final JPM Thoughts, Better Covid Antibodies And Pfizer’s Non-Profit Pricing

Pfizer Covid-19 Bivalent Vaccine And Stroke Risk: What You Need To Know

No Increased Stroke Risk Linked to Pfizer’s Covid Boosters, Federal Officials Say

Gov. DeSantis Calls For Grand Jury To Investigate Vaccines As Covid-19 Increases In Florida

New RSV vaccine given in pregnancy protects newborns from illness, Pfizer says

First RSV Vaccine On The Horizon—Pfizer Touts Strong Trial Results As Children’s Hospitals Count Soaring Cases

Moderna Sues Pfizer and BioNTech Over Covid Vaccine Technology

Pfizer And BioNTech Ask FDA To Authorize Omicron Covid Booster

Teens’ Protection From Pfizer’s Covid Shot Fades Weeks After Vaccination—But Shot Still Wards Off Serious Illness, Study Finds

F.D.A. Panel Recommends Agency Clear Pfizer and Moderna Vaccines for Young Children

Pfizer Vaccine Effective in Children Under 5, the F.D.A. Says

Pfizer Asks FDA To Greenlight Covid Vaccine For Children Under 5

Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5

Paxlovid Rebound: FDA Investigating Reports Of Covid-19 Relapses After Taking Pfizer Antiviral

Covid-19 rebound seen in some people after taking Pfizer drug Paxlovid

mRNA vaccines like Pfizer and Moderna fare better against COVID-19 variants of concern